The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Metastatic Prostate Cancer Treatment Market Research Report 2025
Synopsis
Metastatic prostate cancer is a type of prostate cancer which spreads to the other parts of body such as bones or lymph nodes.
The global Metastatic Prostate Cancer Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Metastatic Prostate Cancer Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Metastatic Prostate Cancer Treatment.
Report Scope
The Metastatic Prostate Cancer Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Metastatic Prostate Cancer Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Metastatic Prostate Cancer Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AB Science
BeiGene
eFFECTOR Therapeutics
Immunomedics(Gilead Sciences, Inc.)
Myovant Biosciences
SeleXel
Zenith Epigenetics Ltd.
VasGene Therapeutics, Inc.
Telix Pharmaceuticals
Arvinas Inc.
Amgen
Genentech
Segment by Type
Mono
Combination
Mono/Combination
Segment by Application
Hospital
Drug Store
Online Pharmacy
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Metastatic Prostate Cancer Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Metastatic prostate cancer is a type of prostate cancer which spreads to the other parts of body such as bones or lymph nodes.
The global Metastatic Prostate Cancer Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Metastatic Prostate Cancer Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Metastatic Prostate Cancer Treatment.
Report Scope
The Metastatic Prostate Cancer Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Metastatic Prostate Cancer Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Metastatic Prostate Cancer Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AB Science
BeiGene
eFFECTOR Therapeutics
Immunomedics(Gilead Sciences, Inc.)
Myovant Biosciences
SeleXel
Zenith Epigenetics Ltd.
VasGene Therapeutics, Inc.
Telix Pharmaceuticals
Arvinas Inc.
Amgen
Genentech
Segment by Type
Mono
Combination
Mono/Combination
Segment by Application
Hospital
Drug Store
Online Pharmacy
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Metastatic Prostate Cancer Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Metastatic Prostate Cancer Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Mono
1.2.3 Combination
1.2.4 Mono/Combination
1.3 Market by Application
1.3.1 Global Metastatic Prostate Cancer Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Drug Store
1.3.4 Online Pharmacy
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Metastatic Prostate Cancer Treatment Market Perspective (2019-2030)
2.2 Metastatic Prostate Cancer Treatment Growth Trends by Region
2.2.1 Global Metastatic Prostate Cancer Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Metastatic Prostate Cancer Treatment Historic Market Size by Region (2019-2024)
2.2.3 Metastatic Prostate Cancer Treatment Forecasted Market Size by Region (2025-2030)
2.3 Metastatic Prostate Cancer Treatment Market Dynamics
2.3.1 Metastatic Prostate Cancer Treatment Industry Trends
2.3.2 Metastatic Prostate Cancer Treatment Market Drivers
2.3.3 Metastatic Prostate Cancer Treatment Market Challenges
2.3.4 Metastatic Prostate Cancer Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Metastatic Prostate Cancer Treatment Players by Revenue
3.1.1 Global Top Metastatic Prostate Cancer Treatment Players by Revenue (2019-2024)
3.1.2 Global Metastatic Prostate Cancer Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Metastatic Prostate Cancer Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Metastatic Prostate Cancer Treatment Revenue
3.4 Global Metastatic Prostate Cancer Treatment Market Concentration Ratio
3.4.1 Global Metastatic Prostate Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Metastatic Prostate Cancer Treatment Revenue in 2023
3.5 Metastatic Prostate Cancer Treatment Key Players Head office and Area Served
3.6 Key Players Metastatic Prostate Cancer Treatment Product Solution and Service
3.7 Date of Enter into Metastatic Prostate Cancer Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Metastatic Prostate Cancer Treatment Breakdown Data by Type
4.1 Global Metastatic Prostate Cancer Treatment Historic Market Size by Type (2019-2024)
4.2 Global Metastatic Prostate Cancer Treatment Forecasted Market Size by Type (2025-2030)
5 Metastatic Prostate Cancer Treatment Breakdown Data by Application
5.1 Global Metastatic Prostate Cancer Treatment Historic Market Size by Application (2019-2024)
5.2 Global Metastatic Prostate Cancer Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Metastatic Prostate Cancer Treatment Market Size (2019-2030)
6.2 North America Metastatic Prostate Cancer Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Metastatic Prostate Cancer Treatment Market Size by Country (2019-2024)
6.4 North America Metastatic Prostate Cancer Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Metastatic Prostate Cancer Treatment Market Size (2019-2030)
7.2 Europe Metastatic Prostate Cancer Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Metastatic Prostate Cancer Treatment Market Size by Country (2019-2024)
7.4 Europe Metastatic Prostate Cancer Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Metastatic Prostate Cancer Treatment Market Size (2019-2030)
8.2 Asia-Pacific Metastatic Prostate Cancer Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Metastatic Prostate Cancer Treatment Market Size (2019-2030)
9.2 Latin America Metastatic Prostate Cancer Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Metastatic Prostate Cancer Treatment Market Size by Country (2019-2024)
9.4 Latin America Metastatic Prostate Cancer Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Metastatic Prostate Cancer Treatment Market Size (2019-2030)
10.2 Middle East & Africa Metastatic Prostate Cancer Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AB Science
11.1.1 AB Science Company Detail
11.1.2 AB Science Business Overview
11.1.3 AB Science Metastatic Prostate Cancer Treatment Introduction
11.1.4 AB Science Revenue in Metastatic Prostate Cancer Treatment Business (2019-2024)
11.1.5 AB Science Recent Development
11.2 BeiGene
11.2.1 BeiGene Company Detail
11.2.2 BeiGene Business Overview
11.2.3 BeiGene Metastatic Prostate Cancer Treatment Introduction
11.2.4 BeiGene Revenue in Metastatic Prostate Cancer Treatment Business (2019-2024)
11.2.5 BeiGene Recent Development
11.3 eFFECTOR Therapeutics
11.3.1 eFFECTOR Therapeutics Company Detail
11.3.2 eFFECTOR Therapeutics Business Overview
11.3.3 eFFECTOR Therapeutics Metastatic Prostate Cancer Treatment Introduction
11.3.4 eFFECTOR Therapeutics Revenue in Metastatic Prostate Cancer Treatment Business (2019-2024)
11.3.5 eFFECTOR Therapeutics Recent Development
11.4 Immunomedics(Gilead Sciences, Inc.)
11.4.1 Immunomedics(Gilead Sciences, Inc.) Company Detail
11.4.2 Immunomedics(Gilead Sciences, Inc.) Business Overview
11.4.3 Immunomedics(Gilead Sciences, Inc.) Metastatic Prostate Cancer Treatment Introduction
11.4.4 Immunomedics(Gilead Sciences, Inc.) Revenue in Metastatic Prostate Cancer Treatment Business (2019-2024)
11.4.5 Immunomedics(Gilead Sciences, Inc.) Recent Development
11.5 Myovant Biosciences
11.5.1 Myovant Biosciences Company Detail
11.5.2 Myovant Biosciences Business Overview
11.5.3 Myovant Biosciences Metastatic Prostate Cancer Treatment Introduction
11.5.4 Myovant Biosciences Revenue in Metastatic Prostate Cancer Treatment Business (2019-2024)
11.5.5 Myovant Biosciences Recent Development
11.6 SeleXel
11.6.1 SeleXel Company Detail
11.6.2 SeleXel Business Overview
11.6.3 SeleXel Metastatic Prostate Cancer Treatment Introduction
11.6.4 SeleXel Revenue in Metastatic Prostate Cancer Treatment Business (2019-2024)
11.6.5 SeleXel Recent Development
11.7 Zenith Epigenetics Ltd.
11.7.1 Zenith Epigenetics Ltd. Company Detail
11.7.2 Zenith Epigenetics Ltd. Business Overview
11.7.3 Zenith Epigenetics Ltd. Metastatic Prostate Cancer Treatment Introduction
11.7.4 Zenith Epigenetics Ltd. Revenue in Metastatic Prostate Cancer Treatment Business (2019-2024)
11.7.5 Zenith Epigenetics Ltd. Recent Development
11.8 VasGene Therapeutics, Inc.
11.8.1 VasGene Therapeutics, Inc. Company Detail
11.8.2 VasGene Therapeutics, Inc. Business Overview
11.8.3 VasGene Therapeutics, Inc. Metastatic Prostate Cancer Treatment Introduction
11.8.4 VasGene Therapeutics, Inc. Revenue in Metastatic Prostate Cancer Treatment Business (2019-2024)
11.8.5 VasGene Therapeutics, Inc. Recent Development
11.9 Telix Pharmaceuticals
11.9.1 Telix Pharmaceuticals Company Detail
11.9.2 Telix Pharmaceuticals Business Overview
11.9.3 Telix Pharmaceuticals Metastatic Prostate Cancer Treatment Introduction
11.9.4 Telix Pharmaceuticals Revenue in Metastatic Prostate Cancer Treatment Business (2019-2024)
11.9.5 Telix Pharmaceuticals Recent Development
11.10 Arvinas Inc.
11.10.1 Arvinas Inc. Company Detail
11.10.2 Arvinas Inc. Business Overview
11.10.3 Arvinas Inc. Metastatic Prostate Cancer Treatment Introduction
11.10.4 Arvinas Inc. Revenue in Metastatic Prostate Cancer Treatment Business (2019-2024)
11.10.5 Arvinas Inc. Recent Development
11.11 Amgen
11.11.1 Amgen Company Detail
11.11.2 Amgen Business Overview
11.11.3 Amgen Metastatic Prostate Cancer Treatment Introduction
11.11.4 Amgen Revenue in Metastatic Prostate Cancer Treatment Business (2019-2024)
11.11.5 Amgen Recent Development
11.12 Genentech
11.12.1 Genentech Company Detail
11.12.2 Genentech Business Overview
11.12.3 Genentech Metastatic Prostate Cancer Treatment Introduction
11.12.4 Genentech Revenue in Metastatic Prostate Cancer Treatment Business (2019-2024)
11.12.5 Genentech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Metastatic Prostate Cancer Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Mono
Table 3. Key Players of Combination
Table 4. Key Players of Mono/Combination
Table 5. Global Metastatic Prostate Cancer Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Metastatic Prostate Cancer Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Metastatic Prostate Cancer Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Metastatic Prostate Cancer Treatment Market Share by Region (2019-2024)
Table 9. Global Metastatic Prostate Cancer Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Metastatic Prostate Cancer Treatment Market Share by Region (2025-2030)
Table 11. Metastatic Prostate Cancer Treatment Market Trends
Table 12. Metastatic Prostate Cancer Treatment Market Drivers
Table 13. Metastatic Prostate Cancer Treatment Market Challenges
Table 14. Metastatic Prostate Cancer Treatment Market Restraints
Table 15. Global Metastatic Prostate Cancer Treatment Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Metastatic Prostate Cancer Treatment Market Share by Players (2019-2024)
Table 17. Global Top Metastatic Prostate Cancer Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metastatic Prostate Cancer Treatment as of 2023)
Table 18. Ranking of Global Top Metastatic Prostate Cancer Treatment Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Metastatic Prostate Cancer Treatment Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Metastatic Prostate Cancer Treatment Product Solution and Service
Table 22. Date of Enter into Metastatic Prostate Cancer Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Metastatic Prostate Cancer Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Metastatic Prostate Cancer Treatment Revenue Market Share by Type (2019-2024)
Table 26. Global Metastatic Prostate Cancer Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Metastatic Prostate Cancer Treatment Revenue Market Share by Type (2025-2030)
Table 28. Global Metastatic Prostate Cancer Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Metastatic Prostate Cancer Treatment Revenue Market Share by Application (2019-2024)
Table 30. Global Metastatic Prostate Cancer Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Metastatic Prostate Cancer Treatment Revenue Market Share by Application (2025-2030)
Table 32. North America Metastatic Prostate Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Metastatic Prostate Cancer Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Metastatic Prostate Cancer Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Metastatic Prostate Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Metastatic Prostate Cancer Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Metastatic Prostate Cancer Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Metastatic Prostate Cancer Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Metastatic Prostate Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Metastatic Prostate Cancer Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Metastatic Prostate Cancer Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Metastatic Prostate Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 47. AB Science Company Detail
Table 48. AB Science Business Overview
Table 49. AB Science Metastatic Prostate Cancer Treatment Product
Table 50. AB Science Revenue in Metastatic Prostate Cancer Treatment Business (2019-2024) & (US$ Million)
Table 51. AB Science Recent Development
Table 52. BeiGene Company Detail
Table 53. BeiGene Business Overview
Table 54. BeiGene Metastatic Prostate Cancer Treatment Product
Table 55. BeiGene Revenue in Metastatic Prostate Cancer Treatment Business (2019-2024) & (US$ Million)
Table 56. BeiGene Recent Development
Table 57. eFFECTOR Therapeutics Company Detail
Table 58. eFFECTOR Therapeutics Business Overview
Table 59. eFFECTOR Therapeutics Metastatic Prostate Cancer Treatment Product
Table 60. eFFECTOR Therapeutics Revenue in Metastatic Prostate Cancer Treatment Business (2019-2024) & (US$ Million)
Table 61. eFFECTOR Therapeutics Recent Development
Table 62. Immunomedics(Gilead Sciences, Inc.) Company Detail
Table 63. Immunomedics(Gilead Sciences, Inc.) Business Overview
Table 64. Immunomedics(Gilead Sciences, Inc.) Metastatic Prostate Cancer Treatment Product
Table 65. Immunomedics(Gilead Sciences, Inc.) Revenue in Metastatic Prostate Cancer Treatment Business (2019-2024) & (US$ Million)
Table 66. Immunomedics(Gilead Sciences, Inc.) Recent Development
Table 67. Myovant Biosciences Company Detail
Table 68. Myovant Biosciences Business Overview
Table 69. Myovant Biosciences Metastatic Prostate Cancer Treatment Product
Table 70. Myovant Biosciences Revenue in Metastatic Prostate Cancer Treatment Business (2019-2024) & (US$ Million)
Table 71. Myovant Biosciences Recent Development
Table 72. SeleXel Company Detail
Table 73. SeleXel Business Overview
Table 74. SeleXel Metastatic Prostate Cancer Treatment Product
Table 75. SeleXel Revenue in Metastatic Prostate Cancer Treatment Business (2019-2024) & (US$ Million)
Table 76. SeleXel Recent Development
Table 77. Zenith Epigenetics Ltd. Company Detail
Table 78. Zenith Epigenetics Ltd. Business Overview
Table 79. Zenith Epigenetics Ltd. Metastatic Prostate Cancer Treatment Product
Table 80. Zenith Epigenetics Ltd. Revenue in Metastatic Prostate Cancer Treatment Business (2019-2024) & (US$ Million)
Table 81. Zenith Epigenetics Ltd. Recent Development
Table 82. VasGene Therapeutics, Inc. Company Detail
Table 83. VasGene Therapeutics, Inc. Business Overview
Table 84. VasGene Therapeutics, Inc. Metastatic Prostate Cancer Treatment Product
Table 85. VasGene Therapeutics, Inc. Revenue in Metastatic Prostate Cancer Treatment Business (2019-2024) & (US$ Million)
Table 86. VasGene Therapeutics, Inc. Recent Development
Table 87. Telix Pharmaceuticals Company Detail
Table 88. Telix Pharmaceuticals Business Overview
Table 89. Telix Pharmaceuticals Metastatic Prostate Cancer Treatment Product
Table 90. Telix Pharmaceuticals Revenue in Metastatic Prostate Cancer Treatment Business (2019-2024) & (US$ Million)
Table 91. Telix Pharmaceuticals Recent Development
Table 92. Arvinas Inc. Company Detail
Table 93. Arvinas Inc. Business Overview
Table 94. Arvinas Inc. Metastatic Prostate Cancer Treatment Product
Table 95. Arvinas Inc. Revenue in Metastatic Prostate Cancer Treatment Business (2019-2024) & (US$ Million)
Table 96. Arvinas Inc. Recent Development
Table 97. Amgen Company Detail
Table 98. Amgen Business Overview
Table 99. Amgen Metastatic Prostate Cancer Treatment Product
Table 100. Amgen Revenue in Metastatic Prostate Cancer Treatment Business (2019-2024) & (US$ Million)
Table 101. Amgen Recent Development
Table 102. Genentech Company Detail
Table 103. Genentech Business Overview
Table 104. Genentech Metastatic Prostate Cancer Treatment Product
Table 105. Genentech Revenue in Metastatic Prostate Cancer Treatment Business (2019-2024) & (US$ Million)
Table 106. Genentech Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Metastatic Prostate Cancer Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Metastatic Prostate Cancer Treatment Market Share by Type: 2023 VS 2030
Figure 3. Mono Features
Figure 4. Combination Features
Figure 5. Mono/Combination Features
Figure 6. Global Metastatic Prostate Cancer Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Metastatic Prostate Cancer Treatment Market Share by Application: 2023 VS 2030
Figure 8. Hospital Case Studies
Figure 9. Drug Store Case Studies
Figure 10. Online Pharmacy Case Studies
Figure 11. Metastatic Prostate Cancer Treatment Report Years Considered
Figure 12. Global Metastatic Prostate Cancer Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Metastatic Prostate Cancer Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Metastatic Prostate Cancer Treatment Market Share by Region: 2023 VS 2030
Figure 15. Global Metastatic Prostate Cancer Treatment Market Share by Players in 2023
Figure 16. Global Top Metastatic Prostate Cancer Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metastatic Prostate Cancer Treatment as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Metastatic Prostate Cancer Treatment Revenue in 2023
Figure 18. North America Metastatic Prostate Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Metastatic Prostate Cancer Treatment Market Share by Country (2019-2030)
Figure 20. United States Metastatic Prostate Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Metastatic Prostate Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Metastatic Prostate Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Metastatic Prostate Cancer Treatment Market Share by Country (2019-2030)
Figure 24. Germany Metastatic Prostate Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Metastatic Prostate Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Metastatic Prostate Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Metastatic Prostate Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Metastatic Prostate Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Metastatic Prostate Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Metastatic Prostate Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Metastatic Prostate Cancer Treatment Market Share by Region (2019-2030)
Figure 32. China Metastatic Prostate Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Metastatic Prostate Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Metastatic Prostate Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Metastatic Prostate Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Metastatic Prostate Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Metastatic Prostate Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Metastatic Prostate Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Metastatic Prostate Cancer Treatment Market Share by Country (2019-2030)
Figure 40. Mexico Metastatic Prostate Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Metastatic Prostate Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Metastatic Prostate Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Metastatic Prostate Cancer Treatment Market Share by Country (2019-2030)
Figure 44. Turkey Metastatic Prostate Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Metastatic Prostate Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. AB Science Revenue Growth Rate in Metastatic Prostate Cancer Treatment Business (2019-2024)
Figure 47. BeiGene Revenue Growth Rate in Metastatic Prostate Cancer Treatment Business (2019-2024)
Figure 48. eFFECTOR Therapeutics Revenue Growth Rate in Metastatic Prostate Cancer Treatment Business (2019-2024)
Figure 49. Immunomedics(Gilead Sciences, Inc.) Revenue Growth Rate in Metastatic Prostate Cancer Treatment Business (2019-2024)
Figure 50. Myovant Biosciences Revenue Growth Rate in Metastatic Prostate Cancer Treatment Business (2019-2024)
Figure 51. SeleXel Revenue Growth Rate in Metastatic Prostate Cancer Treatment Business (2019-2024)
Figure 52. Zenith Epigenetics Ltd. Revenue Growth Rate in Metastatic Prostate Cancer Treatment Business (2019-2024)
Figure 53. VasGene Therapeutics, Inc. Revenue Growth Rate in Metastatic Prostate Cancer Treatment Business (2019-2024)
Figure 54. Telix Pharmaceuticals Revenue Growth Rate in Metastatic Prostate Cancer Treatment Business (2019-2024)
Figure 55. Arvinas Inc. Revenue Growth Rate in Metastatic Prostate Cancer Treatment Business (2019-2024)
Figure 56. Amgen Revenue Growth Rate in Metastatic Prostate Cancer Treatment Business (2019-2024)
Figure 57. Genentech Revenue Growth Rate in Metastatic Prostate Cancer Treatment Business (2019-2024)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
